Diseases & Disorders
(G80)
990 on File
ROCKY MOUNTAIN HEMOPHILIA AND BLEEDING DISORDERS ASSOCIATION
Financial strength (30%)
72/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$226K
Total Revenue
$244K
Total Expenses
$113K
Net Assets
1
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
89.8%
Fundraising Efficiency
518.7%
Operating Reserve
5.58x
Liability-to-Asset
18.1%
Revenue Diversification
55.3%
Executive Compensation
$92K
Compared with Peers
FY 2025
Compared with 693 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
89.8% | 83.5% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.4% | 10.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.7% | 0.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
518.7% | 15.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.6 mo | 11.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
18.1% | 0.6% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
55.3% | 93.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
1.3% | 7.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
8.1% | 8.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.9% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $226K | $244K | $113K | 89.8% | 1 |
| 2024 | $223K | $225K | $126K | 87.5% | 1 |
| 2023 | $207K | $213K | $126K | 90.8% | 1 |
| 2022 | $207K | $224K | $128K | 94.5% | 3 |
| 2021 | $345K | $227K | N/A | — | 3 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.